68 results
Page 2 of 4
6-K
EX-99.1
clm1r53t
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.1
tub gacfqlv7dxjtcyb
14 Sep 22
Current report (foreign)
10:31am
6-K
EX-99.2
twi i0ca6zwuk5
29 Aug 22
Current report (foreign)
4:00pm
424B5
kg0x4 oe2
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-99.2
rmhv3 h2jnrovc4
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
iwn8wtfi h4hukxks
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
sb7gbfdgn3rluxm c7n0
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.1
ntam b748e9ad331
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am
6-K
EX-99.1
p9udm2 p0wudodoa26
28 Jul 21
Current report (foreign)
9:37am
SUPPL
bhrzm7
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
jol6b6u69pv
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
7shu8ip
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
bg6xbmby3g6
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
lvxjo a26u61
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
ikgbxy8
16 Oct 20
Portage Announces Filing of Q1 Interim Financial Statements; Correction to Salvarx Loan Note Settlement Announcement
4:12pm
6-K
EX-99.1
ngvdgj
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
6-K
EX-99.2
wtl4wdmo
3 Mar 20
Consolidated Interim Financial Statements
12:00am